Dose-related hemodynamic and electrocardiographic effects of the calcium promoter BAY y 5959 in the presence or absence of congestive heart failure

Journal of the American College of Cardiology

Volumn 30, Issue 7, 1997, Pages 1751-1757

  Rousseau, Michel F ^a   Massart, Pierre E ^a   Van Eyll, Christian ^a   Etienne, Jean ^a   Ahn, Sylvie ^a   Schaefer, Hans G ^b   Mueck, Wolfgang ^b   Bornemann, Martin ^b   Pouleur, Hubert ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 CYANO 6 METHYL 4 (3 PHENYL 5 QUINOLINYL) 3 PYRIDINECARBOXYLIC ACID ISOPROPYL ESTER; CALCIUM CHANNEL AFFECTING AGENT; DIHYDROPYRIDINE DERIVATIVE; INOTROPIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DOSE RESPONSE; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE PRESSURE; HEART OUTPUT; HEART PRELOAD; HEMODYNAMIC PARAMETERS; HUMAN; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

EID: 0031543452     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00368-9     Document Type: Article

References (15)

1. Xamoterol in severe heart failure. Lancet. 336:1990;1-6.
2. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 325:1991;1468-1475.
3. Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med. 307:1982;205-211.
4. Antzelevitch C, Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations role of M cells in the generation of U waves, triggered activity and torsade de pointes . J Am Coll Cardiol. 23:1994;259-277.
5. Bechem M, Goldmann S, Gross R, et al. A new type of CA-channel modulation by a novel class of 1,4-dihydropyridines. Life Sci. 60:1997;107-118.
6. Rousseau MF, Hayashida W, van Eyll C, et al. Hemodynamic and cardiac effects of the selective T-type and L-type calcium channel blocking agent mibefradil in patients with varying degrees of left ventricular systolic dysfunction. J Am Coll Cardiol. 28:1996;972-979.
7. Mirsky I. Elastic properties of the myocardium a quantitative approach with physiological and clinical applications . Berne RM, Sperelakis N. Handbook of Physiology, Section 2 The Cardiovascular System . 1979;497-531 Williams & Wilkins, Baltimore.
8. Braunwald E, Ross J Jr, Sonnenblick EH. Methods for assessing cardiac contractility. Braunwald E, Ross J Jr, Sonnenblick EH. Mechanisms of Contraction of the Normal and Failing Heart. 1976;130-165 Little Brown, Boston.
9. Rousseau MF, Veriter C, Detry JMR, Brasseur LA, Pouleur H. Impaired early left ventricular relaxation in coronary artery disease effects of intracoronary nifedipine . Circulation. 62:1980;764-772.
10. Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J. Simultaneous modeling of pharmacokinetics and pharmacodynamics application to d-tubocurarine . Clin Pharmacol Ther. 25:1979;358-371.
11. Uechi M, Sato N, Asai K, Kudej R, Vatner SF. A novel calcium promoter improves inotropic state and mechanical efficiency in conscious dogs with heart failure [abstract]. J Am Coll Cardiol. 29:(Suppl A):1997;323A.
12. Ross J Jr. Acute displacement of the diastolic pressure-volume curve of the left ventricle role of the pericardium and the right ventricle . Circulation. 59:1979;32-37.
13. Guyton AC, Jones CE, Coleman TG. Cardiac Output and Its Regulation. 1973;451 Saunders, Philadelphia.
14. Sato N, Uechi M, Kudej RK, Asai K, Vatner DE, Vatner SF. Comparison of a novel calcium channel agonist and dobutamine in conscious dogs with heart failure [abstract]. J Am Coll Cardiol. 27:(Suppl A):1996;27A.
15. Lehmann MH, Hardy S, Archibald D, Quart B, MacNeil DJ. Sex difference in risk of torsade de pointes with d,1-sotalol. Circulation. 94:1996;2534-2541.